Mariaserena Giliberto

Hypoxia promotes IL-32 expression in myeloma cells, and high expression is associated with poor survival and bone loss

Muhammad Asif Zahoor, Marita Westhrin, Kristin Roseth Aass et al. · Blood Advances · 2017 · 72 citations · Full text

Immunology, Immune Regulation, Cell Death +24

<i>Ex vivo</i> drug sensitivity screening in multiple myeloma identifies drug combinations that act synergistically

Mariaserena Giliberto, Deepak B. Thimiri Govinda Raj, Andrea Cremaschi et al. · Molecular Oncology · 2022 · 19 citations · Full text

Mcl‐1 and Bcl‐xL levels predict responsiveness to dual MEK/Bcl‐2 inhibition in B‐cell malignancies

Katrine Melvold, Mariaserena Giliberto, Linda Karlsen et al. · Molecular Oncology · 2021 · 16 citations · Full text

Bcl‐xl Levels, Mixed-phenotype Acute Leukemia, Immunology +19

Standardized assays to monitor drug sensitivity in hematologic cancers

Pilar Ayuda‐Durán, Johanne U. Hermansen, Mariaserena Giliberto et al. · Cell Death Discovery · 2023 · 16 citations · Full text

Phenotypic deconvolution in heterogeneous cancer cell populations using drug-screening data

Alvaro Köhn‐Luque, Even Moa Myklebust, Dagim Shiferaw Tadele et al. · Cell Reports Methods · 2023 · 11 citations · Full text